Book Review

When VCs say No, It’s Time To Get Creative

Collateral Therapeutics, a San Diego, CA startup negotiated a $500,000 loan from Schering AG on the back of intriguing technology and an assortment of financing and partnership agreements. The company was bought out for over $100 million after a few years. Collateral Therapeutics had excellent science and used a variety of agreements, licenses, technology leveraging and several financing methods to develop itself.

Younger companies today must employ a variety of strategies to get the capital they need. Read about this company’s creative approach to financing as well as hundreds of others and the different tactics and resources they used to secure funding and develop into profitable enterprises, in the new book “When Venture Capitalists Say ‘No’—Creative Financing Strategies & Resources” by Ron Peterson.

Did Henry Ford show Michael Dell how to grow a company?

Dell did many of the same things in the 1990s that Ford used 100 years ago to grow a business, in this case the creative use of the float. These and other lessons on financing a new company are compiled for the first time in When Venture Capitalists Say 'No'--Creative Financing Strategies & Resources. You can download the story of how Ford, a failed businessman with no capital connections put together and financed the Ford Motor Company, starting in a recession year, and what Dell learned along with hundreds of different strategies and thousands of sources of capital. www.threearrowscapital.com has that story as a free download. Just click “The Book” and “Book Introduction.”

This new book—an illustration of proven and best-practices—is filled with stories and techniques for creatively and successfully raising capital for a startup or expanded venture. The focus is on interesting financing stories of life-sciences firms and innovative and lucrative approaches to raising capital among the eighty-one types and thousands of sources referenced. When Venture Capitalists Say “No”—Creative Financing Strategies & Resources has techniques that will prove helpful for any expanding company and hopefully will serve as a primer for firms in how to secure funding. This book is particularly relevant for biotechnology companies dealing with insufficient capital for lengthy research, which is the most common cause of failure.

“When Venture Capitalists Say No” is published by Comanche Press, MD 877-245-3774 or visit www.threearrowscapital.com. The 272-page book sells for $29.95.

 back to: top  reviews  home

Find this book on::
  www.threearrowscapital.com